Transperineal ultrasound-guided radioactive seed implantation for organ- confined carcinoma of the prostate

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 2, 1997, Pages 337-341

  Stokes, Steven H ^a,b   Real, Jack D ^a   Adams, Paul W ^a   Clements, Joseph C ^a   Wuertzer, Scott ^a   Kan, William ^a  

^a Southeast Alabama Medical Center   (United States)

^b NONE   (United States)

Author keywords

Brachytherapy; Morbidity; Prostate carcinoma

Indexed keywords

MICROSPHERE I 125; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CARCINOMA;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0030929724     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00508-1     Document Type: Article

References (14)

1. Boring, C. C. Cancer statistics, CA 44:7-26; 1994.
2. Blasko, J. C.; Radge, H.; Schumacher, D. Transperineal percutaneous iodine 125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether./Hyperthermia Oncol. 3:131; 1987.
3. Blasko, J. C.; Grimm, P. D.; Ragde, H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin. Radiat. Oncol. 3:240; 1993.
4. Deblasio, D. S.; Hilaris, B. S.; Nori, D.; Fuks, Z.; Whitmore, W. F.; Fair, W. R.; Anderson, L. L. Permanent interstitial implantation of prostatic cancer in the 1980's. Endocuriether./Hyperthermia Oncol. 4:193; 1988.
5. Giles, G. M.; Brady, L. W. Iodine implantation after lymphadenectomy in early carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 12:2117; 1986.
6. Holm, H. H.; Juul, N.; Pedersen, J. F.; Hansen, H.; Stroyer, I. Transperineal iodine 125 seed implantation in prostatic cancer guided by transrectal ultrasonography. J. Urol. 130:283; 1993.
7. Kavadi, V. S.; Zagars, G. K.; Pollack, A. Serum prostate specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications. Int. J. Radiat. Oncol. Biol. Phys. 30(2):279-284; 1994.
8. Kim, R. Y.; Bueschen, A. J.; Salter, M. M. Retropubic iodine 125 seed implantation in the management of prostate cancer. Endocuriether./Hyperthermia Oncol. 5:141; 1989.
9. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer P. F. I-125 interstitial implantation for prostate cancer. Cancer 63:2415; 1989.
10. Lawrence, K.; Wallner, K.; Roy, J.; Zelefsky, M.; Anterbury, E.; Fuks, Z.; Harrison, L. Treatment related symptoms during the first year following transperineal 1-125 prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 28(4):985-990; 1994.
11. Lee, F.; Torp-Pedersen, S.; Meiselman, L.; et al. Transrectal ultrasound in the diagnosis and staging of local disease after 1-125 seed implantation for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 15:1453; 1988.
12. Ragde, H.; Blasko, J. C.; Schumacher, D.; Grimm, P. D.; Cuningham, D. L.; Sylvester, J.; Mate, T. P. Use of transrectal ultrasound in transperineal iodine 125 seeding for prostate cancer: Methodology. J. Endourol. 3:209; 1989.
13. Wallner, K.; Roy, J.; Zelefsky, M.; Fuks, Z.; Harrison, L. Short-term freedom from disease progression of the 1-125 prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 30(2):405-409; 1994.
14. Zagars, G. K.; Sherman, N. E.; Babaian, R. J. Prostate specific antigen and external beam radiation therapy in prostate cancer. Cancer 67:412; 1991.